Author + information
- Anselm K. Gitt,
- Matthias Hochadel,
- Francois Schiele,
- Wojtek Wojakowski,
- Michal Tendera,
- Ralf Zahn and
- Uwe Zeymer
Patients with diabetes (Diab) develop renal failure (RF) as end organ damage. It is unclear if RF in diabetics might be the driver of impaired outcome in STEMI.
In 2006 to 2008, consecutive patients with ACS were enrolled into the EHS-ACS-Registry to document treatment and hospital outcome. We examined the impact of Diab and RF (GFR < 60ml/kg/min) on hospital outcome in patients with STEMI.
Of all ACS, 8,646 presented with STEMI. Patients with RF were older and more often suffered from co-morbidities than patients without RF independent of the presence of Diab. Both Diab and RF were predictors of mortality, which was highest in those patients with both diseases.
In patients with STEMI, known Diab as well as RF were independent predictors of increased hospital mortality.
|Female Gender (%)||26.2||36.8||30.1||37.1|
|Prior MI (%)||12.9||19.5||32.5||39.5|
|Prior PCI (%)||7.1||10.5||14.3||24.8|
|Prior CABG (%)||1.6||3.1||5.6||10.8|
|Prior Stroke (%)||4.0||7.8||12.8||17.0|
|Killip 4 (%)||3.4||4.5||8.7||3.4|
|Multivessel disease (%)||51.3||62.3||69.6||75.8|
|Primary PCI (%)||57.0||58.0||45.6||48.2|
Poster Sessions, Expo North
Sunday, March 10, 2013, 3:45 p.m.-4:30 p.m.
Session Title: Comorbidity and ACS: COPD, Renal Dysfunction, Diabetes
Abstract Category: 1. Acute Coronary Syndromes: Clinical
Presentation Number: 1257-192
- 2013 American College of Cardiology Foundation